SUPRIYA LIFESCIENCE
Back to Balance Sheet
|
SUPRIYA LIFESCIENCE Last 5 Year Total Liabilities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹1,357 Cr | ₹1,117 Cr | ₹924 Cr | ₹820 Cr | ₹735 Cr |
What is the latest Total Liabilities ratio of SUPRIYA LIFESCIENCE ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹1,357 Cr |
| Mar2025 | ₹1,117 Cr |
| Mar2024 | ₹924 Cr |
| Mar2023 | ₹820 Cr |
| Mar2022 | ₹735 Cr |
How is Total Liabilities of SUPRIYA LIFESCIENCE Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,357 Cr | 21.46 | |
| Mar2025 | ₹1,117 Cr | 20.94 | |
| Mar2024 | ₹924 Cr | 12.63 | |
| Mar2023 | ₹820 Cr | 11.64 | |
| Mar2022 | ₹735 Cr | - | |
Compare Total Liabilities of peers of SUPRIYA LIFESCIENCE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUPRIYA LIFESCIENCE | ₹7,166.1 Cr | -6.4% | 4.1% | 25.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,861.0 Cr | -2% | -6.1% | 12.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹254,319.0 Cr | 3.2% | 5.3% | 67.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,153.0 Cr | -1.9% | -2.9% | 32.7% | Stock Analytics | |
| CIPLA | ₹107,406.0 Cr | -1.5% | -4% | -10.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,362.0 Cr | -2.7% | 4.2% | -1.2% | Stock Analytics | |
SUPRIYA LIFESCIENCE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUPRIYA LIFESCIENCE | -6.4% |
4.1% |
25.6% |
| SENSEX | 0.2% |
-4.6% |
-9.6% |
You may also like the below Video Courses